These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

87 related articles for article (PubMed ID: 14573728)

  • 1. Novel risk markers and clinical practice.
    Manolio T
    N Engl J Med; 2003 Oct; 349(17):1587-9. PubMed ID: 14573728
    [No Abstract]   [Full Text] [Related]  

  • 2. Glutathione peroxidase 1 activity and cardiovascular events in patients with coronary artery disease.
    Blankenberg S; Rupprecht HJ; Bickel C; Torzewski M; Hafner G; Tiret L; Smieja M; Cambien F; Meyer J; Lackner KJ;
    N Engl J Med; 2003 Oct; 349(17):1605-13. PubMed ID: 14573732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic value of myeloperoxidase in coronary artery disease: comparison of unstable and stable angina patients.
    Roman RM; Camargo PV; Borges FK; Rossini AP; Polanczyk CA
    Coron Artery Dis; 2010 May; 21(3):129-36. PubMed ID: 20305551
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel cardiac markers.
    Alder R
    Adv Nurse Pract; 2009 Jun; 17(6):24-7; quiz 28. PubMed ID: 20000180
    [No Abstract]   [Full Text] [Related]  

  • 5. Lipoprotein-associated phospholipase A2: an independent predictor of coronary artery disease events in primary and secondary prevention.
    Anderson JL
    Am J Cardiol; 2008 Jun; 101(12A):23F-33F. PubMed ID: 18549868
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A better way to predict the outcome in acute pancreatitis?
    Windsor JA
    Am J Gastroenterol; 2010 Jul; 105(7):1671-3. PubMed ID: 20606665
    [No Abstract]   [Full Text] [Related]  

  • 7. Clinical inquiries. How useful is high-sensitivity CRP as a risk factor for coronary artery disease?
    Hull SK; Collins LJ; Saseen JJ
    J Fam Pract; 2005 Mar; 54(3):268, 271-2. PubMed ID: 15755382
    [No Abstract]   [Full Text] [Related]  

  • 8. Risk assessment and predictive value of coronary artery disease testing.
    Shaw LJ; Narula J
    J Nucl Med; 2009 Aug; 50(8):1296-306. PubMed ID: 19652216
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidized phospholipids, lipoprotein(a), lipoprotein-associated phospholipase A2 activity, and 10-year cardiovascular outcomes: prospective results from the Bruneck study.
    Kiechl S; Willeit J; Mayr M; Viehweider B; Oberhollenzer M; Kronenberg F; Wiedermann CJ; Oberthaler S; Xu Q; Witztum JL; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2007 Aug; 27(8):1788-95. PubMed ID: 17541022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Homocysteine--are we making a mountain out of a molehill?
    Kumar AV; Lokhandwala Y
    J Assoc Physicians India; 2002 Oct; 50():1227-8. PubMed ID: 12568202
    [No Abstract]   [Full Text] [Related]  

  • 11. Plasma matrix metalloproteinase-3 level is an independent prognostic factor in stable coronary artery disease.
    Wu TC; Leu HB; Lin WT; Lin CP; Lin SJ; Chen JW
    Eur J Clin Invest; 2005 Sep; 35(9):537-45. PubMed ID: 16128859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. C-reactive protein: risk assessment in the primary prevention of atherosclerotic disease. Has the time come for including it in the risk profile?
    Koenig W
    Ital Heart J; 2001 Mar; 2(3):157-63. PubMed ID: 11305526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. After menopause: novel marker helps to identify women at risk for heart disease.
    Lewis SL
    J Fam Pract; 2004 Jul; Suppl():S18-24. PubMed ID: 15251109
    [No Abstract]   [Full Text] [Related]  

  • 14. The role of high sensitivity C-reactive protein in coronary artery disease risk prediction: a review.
    Abou Diwan CH; Oghlakian GO; Antonios SI; Otrock ZK; Rebeiz AG
    J Med Liban; 2004; 52(1):39-47. PubMed ID: 15881701
    [No Abstract]   [Full Text] [Related]  

  • 15. Fecal lactoferrin, myeloperoxidase and serum C-reactive are effective biomarkers in the assessment of disease activity and severity in patients with idiopathic ulcerative colitis.
    Masoodi I; Kochhar R; Dutta U; Vaishnavi C; Prasad KK; Vaiphei K; Kaur S; Singh K
    J Gastroenterol Hepatol; 2009 Nov; 24(11):1768-74. PubMed ID: 20136960
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk stratification using stress echocardiography: incremental prognostic value over historic, clinical, and stress electrocardiographic variables across a wide spectrum of bayesian pretest probabilities for coronary artery disease.
    Bangalore S; Gopinath D; Yao SS; Chaudhry FA
    J Am Soc Echocardiogr; 2007 Mar; 20(3):244-52. PubMed ID: 17336749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Value of CRP in coronary risk determination.
    Mehta JL; Sukhija R; Romeo F; Sepulveda JL
    Indian Heart J; 2007; 59(2):173-7. PubMed ID: 19122252
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High sensitive C-reactive protein: a novel biochemical markers and its role in coronary artery disease.
    Mitra B; Panja M
    J Assoc Physicians India; 2005 Jan; 53():25-32. PubMed ID: 15857009
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging cardiac markers in coronary disease: role of brain natriuretic peptide and other biomarkers.
    Palazzuoli A; Iovine F; Gallotta M; Nuti R
    Minerva Cardioangiol; 2007 Aug; 55(4):491-6. PubMed ID: 17653025
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloperoxidase as a diagnostic and prognostic marker in cardiology: beware of pre-analytical factors that may influence results.
    Schindhelm RK; van der Zwan LP
    Int J Lab Hematol; 2011 Jun; 33(3):332. PubMed ID: 21118386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.